Pancreatic Cancer Research

ResearcherUniversity of TurinActive in the last 2 years

Silvia Arpicco

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4754-6591; OpenAlex author ID A5103127826. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 8

  1. Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer. Co-author DOI 10.1002/wnan.70067↗
  2. Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs. Co-author DOI 10.1016/j.jcis.2023.12.166↗
  3. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemc… Co-author DOI 10.3390/cells13090730↗
  4. MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells. Co-author DOI 10.1016/j.bbamcr.2020.118824↗
  5. Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine. Co-author DOI 10.3390/ijms22010029↗
  6. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes. Last author DOI 10.1016/j.bbagen.2018.09.018↗
  7. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity. Co-author DOI 10.1016/j.bbamem.2013.01.020↗
  8. Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives. Co-author DOI 10.1016/j.freeradbiomed.2011.01.001↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Valeria Bincoletto · 2 shared papers, 2024–2026 · strength 0.57
  2. Giorgia Urbinati · 1 shared paper, 2026 · strength 0.36
  3. Maria Raffaella Greco · 2 shared papers, 2020–2024 · strength 0.28
  4. Tiago M. A. Carvalho · 2 shared papers, 2020–2024 · strength 0.28
  5. Stephan J. Reshkin · 2 shared papers, 2020–2024 · strength 0.28
  6. Rosa Angela Cardone · 2 shared papers, 2020–2024 · strength 0.28
  7. Massimo Donadelli · 4 shared papers, 2011–2020 · strength 0.27
  8. Elisa Dalla Pozza · 4 shared papers, 2011–2020 · strength 0.24
  9. Marta Palmieri · 4 shared papers, 2011–2020 · strength 0.24
  10. Ilaria Dando · 4 shared papers, 2011–2020 · strength 0.24
  11. Michał Bartkowski · 1 shared paper, 2024 · strength 0.21
  12. Silvia Giordani · 1 shared paper, 2024 · strength 0.21
  13. Tomas Koltai · 1 shared paper, 2024 · strength 0.18
  14. Natalia B. Prevarskaya · 1 shared paper, 2024 · strength 0.18
  15. Madelaine Magalì Audero · 1 shared paper, 2024 · strength 0.18
  16. Alessandra Fiorio · 1 shared paper, 2024 · strength 0.18
  17. Stefania Forciniti · 2 shared papers, 2019–2020 · strength 0.18
  18. Francesca Masetto · 1 shared paper, 2020 · strength 0.11
  19. Raffaella Pacchiana · 1 shared paper, 2020 · strength 0.09
  20. Cristian Andres Carmona‐Carmona · 1 shared paper, 2020 · strength 0.09
  21. Giulia Ambrosini · 1 shared paper, 2020 · strength 0.09
  22. Alessandro Marengo · 1 shared paper, 2019 · strength 0.09
  23. Christopher Heeschen · 1 shared paper, 2019 · strength 0.09
  24. Aldo Scarpa · 2 shared papers, 2011–2013 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.